Analyst Coverage

Joel Beatty, M.D.
Goldman, Sachs & Co.
Paul Choi
Michael Yee
Mizuho Securities USA
Difei Yang, Ph.D.
Piper Jaffray & Co.
Danielle C. Brill, Pharm.D.
Adam  A. Walsh, M.D.
SVB Leerink
Geoffrey C. Porges, M.B.B.S.
William Blair
Andy T. Hsieh, Ph.D.

FibroGen, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding FibroGen, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of FibroGen, Inc. or its management. FibroGen, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.